PDE 10 inhibitors (Lundbeck)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePDE 10 inhibitors (Lundbeck)
Drug Alias NameN-methylanilide/N-methylbenzamide derivatives (Lundbeck)PDE 10A inhibitors (Lundbeck)Lu-AE90074Lu-074
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsPsychotic DisordersCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesH. Lundbeck A/S
Inactive CompaniesN/A
Active IndicationsPsychotic DisordersCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A